Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Peptide YY3-36 reduces food intake through taste aversion

April 7, 2005

Ligand earns milestone from TAP's IND filing

April 7, 2005

Phase III trial completed for Bio-E-Gel

April 7, 2005

Chugai ceases development of orlistat in Japan

April 6, 2005

Clinical trials confirm the good safety profile and low immunogenicity of DX-88

April 6, 2005

Novel antidiabetic agents imparted by Roche

April 6, 2005

New agents for the treatment of lipoprotein disorders reported by Forbes Medi-Tech

April 6, 2005

Metabasis updates CS-917 trials status

April 6, 2005

Novo Nordisk receives extended E.U. approvals for diabetes drugs

April 5, 2005

NuvaRing reported as effective as an oral combination of contraceptives

April 4, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...